| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.183 | 54.212 | 61.711 | 79.218 | 84.705 | 102.817 | 126.981 | 135.398 | 160.411 | 187.174 |
| Total Income - EUR | 62.868 | 57.407 | 62.564 | 79.233 | 84.705 | 102.818 | 126.981 | 135.399 | 162.433 | 187.174 |
| Total Expenses - EUR | 34.595 | 29.669 | 27.372 | 29.568 | 43.868 | 36.728 | 31.613 | 36.365 | 50.742 | 78.632 |
| Gross Profit/Loss - EUR | 28.273 | 27.738 | 35.192 | 49.666 | 40.837 | 66.089 | 95.368 | 99.034 | 111.692 | 108.543 |
| Net Profit/Loss - EUR | 26.387 | 27.164 | 34.567 | 48.873 | 39.990 | 65.131 | 94.098 | 97.680 | 110.067 | 102.927 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Neurolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.625 | 7.247 | 3.951 | 3.317 | 6.360 | 4.722 | 15.968 | 13.608 | 33.887 | 24.855 |
| Current Assets | 169.851 | 80.111 | 31.689 | 80.722 | 38.587 | 61.987 | 79.800 | 85.962 | 80.509 | 81.725 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1 | 5.081 | 3.296 | 5.205 | 8.366 | 5.314 | 8.372 | 50.130 | 62.797 | 49.250 |
| Cash | 169.850 | 75.030 | 28.393 | 75.517 | 30.221 | 56.674 | 71.428 | 35.832 | 17.712 | 32.475 |
| Shareholders Funds | 181.382 | 84.222 | 34.619 | 82.857 | 40.040 | 65.180 | 94.147 | 97.729 | 110.116 | 102.975 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.094 | 3.136 | 1.020 | 1.181 | 8.503 | 1.529 | 1.621 | 1.841 | 4.280 | 3.604 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurolife Srl